Literature DB >> 1578223

Human infections with Borna disease virus: seroprevalence in patients with chronic diseases and healthy individuals.

L Bode1, S Riegel, W Lange, H Ludwig.   

Abstract

Borna disease virus (BDV) is as yet an unclassified infectious agent which causes a neurologic disease in horses and sheep and is transmissible to other animal species. Human sera were tested for BDV-specific antibodies by immunofluorescence and immunoprecipitation. The sera were collected from three thousand subjects in Europe, the USA, and Africa classified by clinical syndromes/infectious diseases, and from healthy controls. In all three continents, positive serum samples were detected which recognized the major BDV antigen of 38/40 KD present in the nuclei of infected cells. In contrast to 2% of seropositives among the normal population, significantly higher prevalences (13-14%) were present among patients with chronic progressive diseases of the brain and the immune system. In children, antibody frequencies were two to four times higher than in adults. The results suggest a latent infection with BDV in humans leading to low antigen expression in healthy subjects and frequent reactivation events in chronically ill patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1578223     DOI: 10.1002/jmv.1890360414

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  29 in total

1.  Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells.

Authors:  T Briese; J C de la Torre; A Lewis; H Ludwig; W I Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 2.  Borna disease virus and human disease.

Authors:  K M Carbone
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  No evidence of Borna disease virus-specific antibodies in multiple sclerosis patients in Germany.

Authors:  B Kitze; S Herzog; P Rieckmann; S Poser; J Richt
Journal:  J Neurol       Date:  1996-09       Impact factor: 4.849

4.  Microplate hybridization for Borna disease virus RNA in human peripheral blood mononuclear cells.

Authors:  S Fujiwara; H Takahashi; T Nakaya; Y Nakamura; K Nakamura; K Iwahashi; H Kazamatsuri; S Iritani; N Kuroki; K Ikeda; K Ikuta
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

5. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

6.  Varied persistent life cycles of Borna disease virus in a human oligodendroglioma cell line.

Authors:  Madiha S Ibrahim; Makiko Watanabe; J Alejandro Palacios; Wataru Kamitani; Satoshi Komoto; Takeshi Kobayashi; Keizo Tomonaga; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Unusually high seroprevalence of Borna disease virus in clade E human immunodeficiency virus type 1-infected patients with sexually transmitted diseases in Thailand.

Authors:  W Auwanit; P I Ayuthaya; T Nakaya; S Fujiwara; T Kurata; K Yamanishi; K Ikuta
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

8.  Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present.

Authors:  B Cubitt; J C de la Torre
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Borna disease virus RNA in immunocompromised patients in southwestern France.

Authors:  Emmanuelle Cotto; Didier Neau; Martine Cransac-Neau; Marc Auriacombe; Jean-Luc Pellegrin; Jean-Marie Ragnaud; Anne-Marie Fillet; Magali Belnard; Hervé Fleury; Marie-Edith Lafon
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  Fine structure and morphogenesis of Borna disease virus.

Authors:  T Kohno; T Goto; T Takasaki; C Morita; T Nakaya; K Ikuta; I Kurane; K Sano; M Nakai
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.